Department of Pharmacology and Toxicology, University of Arizona, Tucson, 85721, USA.
Antioxid Redox Signal. 2010 Dec 1;13(11):1699-712. doi: 10.1089/ars.2010.3211. Epub 2010 Aug 14.
Nrf2 is a transcription factor that has emerged as the cell's main defense mechanism against many harmful environmental toxicants and carcinogens. Nrf2 is negatively regulated by Keap1, a substrate adaptor protein for the Cullin3 (Cul3)-containing E3-ligase complex, which targets Nrf2 for ubiquitination and degradation by the ubiquitin proteasome system (UPS). Recent evidence suggests that constitutive activation of Nrf2, due to mutations in Keap1 or Nrf2, is prominent in many cancer types and contributes to chemoresistance. Regulation of Nrf2 by the Cul3-Keap1-E3 ligase provides strong evidence that tight regulation of Cullin-ring ligases (CRLs) is imperative to maintain cellular homeostasis. There are seven known Cullin proteins that form various CRL complexes. They are regulated by neddylation/deneddylation, ubiquitination/deubiquitination, CAND1-assisted complex assembly/disassembly, and subunit dimerization. In this review, we will discuss the regulation of each CRL using the Cul3-Keap1-E3 ligase complex as the primary focus. The substrates of CRLs are involved in many signaling pathways. Therefore, deregulation of CRLs affects several cellular processes, including cell cycle arrest, DNA repair, cell proliferation, senescence, and death, which may lead to many human diseases, including cancer. This makes CRLs a promising target for novel cancer drug therapies.
Nrf2 是一种转录因子,已成为细胞抵抗许多有害环境毒物和致癌物的主要防御机制。Nrf2 受 Keap1 负调控,Keap1 是 Cullin3(Cul3)含 E3 连接酶复合物的底物衔接蛋白,该复合物将 Nrf2 作为泛素蛋白酶体系统(UPS)的靶标进行泛素化和降解。最近的证据表明,由于 Keap1 或 Nrf2 中的突变,Nrf2 的组成性激活在许多癌症类型中很明显,并导致化疗耐药。Cul3-Keap1-E3 连接酶对 Nrf2 的调节有力地表明,严格调节 Cullin 环连接酶(CRLs)对于维持细胞内稳态至关重要。有七种已知的 Cullin 蛋白形成各种 CRL 复合物。它们受 neddylation/deneddylation、ubiquitination/deubiquitination、CAND1 辅助的复合物组装/解体以及亚基二聚化调节。在这篇综述中,我们将讨论使用 Cul3-Keap1-E3 连接酶复合物作为主要焦点的每种 CRL 的调节。CRLs 的底物参与许多信号通路。因此,CRLs 的失调会影响多种细胞过程,包括细胞周期停滞、DNA 修复、细胞增殖、衰老和死亡,这可能导致许多人类疾病,包括癌症。这使得 CRLs 成为新型癌症药物治疗的有前途的靶标。